Generics Leader Leverage Mepha Schweiz AG’s position as a top Swiss generics player with a broad portfolio of over 230 generic and branded portfolios across ~20 indications to identify cost-effective, high-volume procurement opportunities for medical institutions, pharmacies, and clinics.

Teva Backbone Capitalize on the integration with Teva as the largest global generics group to access international best practices, pricing strategies, and potential co-promotion or distribution partnerships for expanded product offerings in the Swiss market.

Specialty Access Target the Teva Pharma AG specialty portfolio in CNS, oncology, and respiratory areas to identify initiatives for formulary inclusion, patient access programs, and targeted patient-support services in Swiss hospitals and clinics.

Digital Readiness Utilize the tech stack and digital channels (Slick, Moment.js, Bootstrap, Azure, Maps) to propose data-driven digital engagement, e-detailing, and online medical education tools to physicians, pharmacists, and health organizations to drive product penetration.

Healthcare Partnerships Position opportunities around value-driven services and patient quality of life initiatives aligned with Mepha/Teva’s mission, offering collaborations with hospitals, clinics, and patient organizations for affordable access programs and pharmacovigilance collaborations.